Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRay GroupSHSE:688301 -2.07%95 Current Ratio is 3.38 as of Jun. 2026, which is 37% below its 10-year median of 5.37. GuruFocus rates SHSE:688301 with a GF Score™ of 95/100 and a GF Value™ of ¥109.99 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 850 Medical Devices & Instruments companies, iRay Group ranks better than 65.18% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. iRay Group's current ratio for the quarter that ended in Jun. 2026 was 3.38.
iRay Group has a current ratio of 3.38. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for iRay Group's Current Ratio or its related term are showing as below:
SHSE:688301'
s Current Ratio Range Over the Past 10 Years
Min: 2.11 Med: 5.37 Max: 13.67
Current: 3.38
During the past 11 years, iRay Group's highest Current Ratio was 13.67. The lowest was 2.11. And the median was 5.37.
SHSE:688301's Current Ratio is ranked better than 65.18% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs SHSE:688301: 3.38
iRay Group (SHSE:688301) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
iRay Group Current Ratio Related Terms
iRay Group Current Ratio Historical Data
* Premium members only.
The historical data trend for iRay Group's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688301 vs ISRG, BDX, RMD: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, iRay Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRay Group Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRay Group's Current Ratio distribution charts can be found below:
* The bar in red indicates where iRay Group's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRay Group (SHSE:688301) has a Current Ratio of 3.38 as of Jun. 2026. This is 37% below median its historical median of 5.37. Over the past decade, iRay Group's Current Ratio has ranged from 2.11 to 13.67. According to the industry distribution chart, iRay Group ranks #296 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 34.8%.
Is iRay Group's Current Ratio too high?
iRay Group's current Current Ratio of 3.38 is 37% below median its 10-year median of 5.37. Over the past 10 years, this metric has ranged from a low of 2.11 to a high of 13.67. The Medical Devices & Instruments industry median Current Ratio is 2.43. iRay Group's value of 3.38 is 39.1% above this industry median. Based on the distribution chart, iRay Group ranks #296 out of 850 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, iRay Group has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRay Group's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iRay Group ranks #296 out of 850 companies for Current Ratio. This puts iRay Group in the upper half of its industry. The industry median Current Ratio is 2.43. iRay Group's value of 3.38 is 39.1% above this benchmark. Historically, iRay Group's own Current Ratio has ranged from 2.11 to 13.67 over the past decade. While the company's 10-year median is 5.37 vs. the industry median of 2.43, iRay Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.43, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRay Group's current Current Ratio of 3.38 is 39.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRay Group's current Current Ratio is 3.38, which is 37% below median its own 10-year median of 5.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRay Group stock overvalued right now?
Based on GuruFocus' analysis, iRay Group (SHSE:688301) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥109.99, compared to a current price of ¥88.54 — trading 19.5% below its estimated fair value. The current Current Ratio is 3.38, which is 37% below median its 10-year median of 5.37 and 39.1% above the Medical Devices & Instruments industry median of 2.43. iRay Group's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For iRay Group (SHSE:688301), the current Current Ratio is 3.38 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRay Group (SHSE:688301) Overvalued in 2026?
Based on GuruFocus' analysis, iRay Group stock appears to be undervalued.
The current stock price of ¥88.54 is trading 19.5% below its estimated GF Value™ of ¥109.99.
GuruFocus considers iRay Group to be Modestly Undervalued.
Key valuation signals for SHSE:688301:
Current Ratio: 3.38 (37% below median its 10-year median of 5.37)
GF Value™: ¥109.99 vs. price of ¥88.54 (19.5% below fair value)
Industry Position: 39.1% above the Medical Devices & Instruments median (#296 of 850)
No single metric tells the full story. See the SHSE:688301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688301 has been successfully added to your 
